365Telugu.com online news,India, April 30th, 2024: Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), determined by the FDA to be bioequivalent1 to Advil Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC), of Haleon US Holdings, LLC.
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics Inc., USA.
According to Nielsen syndicated data for the latest 52 weeks period ending March 23, 2024, the Advil Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC) market3 achieved annual sales of approximately $84.1 million*.
Glenmark’s current portfolio consists of 195 products authorized for distribution in the U.S. marketplace and 52 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
ఇది కూడా చదవండి: పార్టిసిపేటింగ్ ప్రోడక్టులపై అత్యధిక బోనస్ ప్రకటించిన బజాజ్ అలయంజ్ లైఫ్..
Also read:Bajaj Allianz Life Announces its highest-ever bonus for their participating products
ఇది కూడా చదవండి: కరెరా సమ్మర్ కలెక్షన్ విడుదల చేసిన సన్రైజర్స్ హైదరాబాద్ కెప్టెన్ ప్యాట్ కమిన్స్..
Also read: PAT CUMMINS, THE BRAND AMBASSADOR OF CARRERA & CAPTAIN OF SUNRISERS HYDERABAD LAUNCHED A NEW SUMMER COLLECTION
Also read: Freedom Healthy Cooking Oils and Election Commission join hands for Voter Participation Drive for Lok Sabha Elections 2024
Also read: Mahindra launches the XUV 3XO – the ‘New Disruptor’in compact SUVsPrices start at₹7.49 Lakh..
Also read: Tata Chemicals Limited financial results for the quarter and full year ended March 31, 2024
Also read: ROBUST OVERALL PERFORMANCE, PROPELLED BY GROWTH ACROSS DIVERSIFIED BUSINESSES AND MARGIN EXPANSION